ArticlebioRxiv : the preprint server for biology2025

Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation.

Yang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.